- Home
- GH vs NXE Comparison
GH vs NXE Comparison
Compare GH & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- NXE
- Stock Information
- Founded
- GH 2011
- NXE 2011
- Country
- GH United States
- NXE Canada
- Employees
- GH N/A
- NXE N/A
- Industry
- GH Medical Specialities
- NXE
- Sector
- GH Health Care
- NXE
- Exchange
- GH Nasdaq
- NXE Nasdaq
- Market Cap
- GH 4.9B
- NXE 4.1B
- IPO Year
- GH 2018
- NXE N/A
- Fundamental
- Price
- GH $49.14
- NXE $6.60
- Analyst Decision
- GH Strong Buy
- NXE
- Analyst Count
- GH 20
- NXE 0
- Target Price
- GH $54.35
- NXE N/A
- AVG Volume (30 Days)
- GH 2.2M
- NXE 10.8M
- Earning Date
- GH 08-06-2025
- NXE 08-06-2025
- Dividend Yield
- GH N/A
- NXE N/A
- EPS Growth
- GH N/A
- NXE N/A
- EPS
- GH N/A
- NXE N/A
- Revenue
- GH $773,996,000.00
- NXE N/A
- Revenue This Year
- GH $23.14
- NXE N/A
- Revenue Next Year
- GH $21.42
- NXE N/A
- P/E Ratio
- GH N/A
- NXE N/A
- Revenue Growth
- GH 28.20
- NXE N/A
- 52 Week Low
- GH $20.14
- NXE $3.91
- 52 Week High
- GH $52.92
- NXE $8.96
- Technical
- Relative Strength Index (RSI)
- GH 62.17
- NXE 58.75
- Support Level
- GH $48.00
- NXE $6.43
- Resistance Level
- GH $51.71
- NXE $7.25
- Average True Range (ATR)
- GH 2.67
- NXE 0.27
- MACD
- GH 0.39
- NXE -0.00
- Stochastic Oscillator
- GH 78.60
- NXE 48.43
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About NXE Nexgen Energy Ltd.
NexGen Energy Ltd is a mineral exploration company. It is engaged in the acquisition, exploration, evaluation and development of uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin. The Rook I property hosts the world-class Arrow Zone, the Bow discovery. as well as the discovered Harpoon area located northeast of the Arrow deposit.